NCT05628194Active, not recruiting
ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
SAVE THE BOTTOMS!!!: ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
Source: ClinicalTrials.gov · Last updated 8 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to describe current knowledge and opinions about anal cancer screening among men who have sex with men (MSM), as well as their experience receiving guideline-compliant care aimed at anal cancer risk reduction using a large-scale survey disseminated via social media.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 92 (actual)
- First submitted
- 16 Nov 2022
- Start date
- 8 Jun 2023
- Primary completion date
- 30 Jun 2026
- Lead sponsor
- University of Minnesota
- NCT number
- NCT05628194
What you commit to
- Study type: Observational
- Participants enrolled: 92
- From 8 Jun 2023 to the primary completion date, 30 Jun 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Under the age of 18 years old
Other
- Not living in the United States
- Not born with sex assigned at birth as male
- Does not engage in sex with male partners
Who the study is looking for
- ≥18 years of age
- Current resident of the U.S.
- Engage in anoreceptive intercourse with male partners
- Fluent in English or Spanish
Age in the registry: 18 years to - · Sex: Male · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Minnesota Coordinator of this site? Confirm its status | Minneapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.